ARTICLE | Clinical News
Cortex Pharmaceuticals preclinical data
June 10, 1996 7:00 AM UTC
CORX presented animal data suggesting a role for Ampalex in schizophrenia at the IBC Symposium on Schizophrenia in Philadelphia. Using rats injected with methamphetamine, a model of human psychosis, company researchers and university collaborators showed that the agent could shift the balance of neural activity between the brain cortex and sub-cortical regions, in a manner opposite to the action of methamphetamine. ...